So you’ve got a little data analysis problem. You have some compounds with a range of IC50
values and you’d like to explore the extent that molecular size contributes to
potency/affinity. Here’s one suggestion
for starters. Plot pIC50 against your
favourite measure of molecular size
which could be number of number of non-hydrogen atoms, molecular weight and look at the residuals which tell you how much each compound beats the trend (or is beaten by it). Let’s start by defining pIC50 which you can
calculate from:
pIC50 = -log(IC50/M) 1
You might be asking why I’m not suggesting that you use the
standard Gibbs free energy of binding which is defined by:
ΔG° = RTln(Kd/C°) 2
The main reason for not doing this is that we can’t. You’ll notice that ΔG° is calculated from Kd
and not IC50 and the two are not the same thing even though they both have units of
concentration. Those of you who have
worked on kinase projects may have even used IC50 values measured at different
ATP concentrations to get a better idea how much kick your inhibitors will have
at physiological ATP concentration. Put
another way, you can measure the concentration of sugar in your coffee and plug
this into equation 2 but that does not make what you calculate a standard Gibbs
free energy of binding. If you’ve
measured IC50 then you really should use pIC50 in this analysis. Converting pIC50 to ΔG° is technically incorrect
and arguably pretentious since the converted pIC50 can give the impression that
it is somehow more thermodynamic than that from which it was calculated. Converting pIC50 to ΔG° also introduces
additional units (of energy/mole) and there is always a degree of irony when
these units, which may have been introduced to just make biological data look
more physical, get lost when the results are presented.
So let’s get back to the data analysis problem. Suppose that we’ve plotted pIC50 against number of heavy
(i.e. non-hydrogen) atoms and the next step is to fit the data. Best way to start is to fit a straight line
although you could also fit a curve if the data justifies this. Let’s assume that we’re fitting the straight
line:
pIC50 = A +
B×NHA 3
I realise that using an intercept term (A) will cause a few
eyebrows to become raised. Surely the line of fit
should go through the origin? There is
a problem with this line of thinking and it’s helpful now to talk instead in terms of affinity and ΔG° to
develop the point a bit more. You might
be thinking that in the limit of zero molecular size a compound should have
zero free energy of binding. However, a
zero free energy of binding corresponds to Kd being equal to the standard
concentration and you’ll remember that the choice of standard state is arbitrary. If you must derive insights from thermodynamic
measurements then the very least that you can do is to ensure that any insights you derive are
invariant with respect to the value of the standard concentration.
When you use ligand efficiency (-ΔG°/NHA) you’re effectively assuming
that the value of ΔG° should be directly proportional to the number of heavy
atoms in the ligand molecule. One consequence of defining ligand efficiency in this manner is that relative values of ligand efficiency for compounds with different numbers of heavy atoms will change if you change (as thermodynamics tells us that we are allowed to do) the standard concentration used to define ΔG°. I've droned on enough though and it's time to check out. I will however, leave you with the question of whether it makes sense to try to correct ligand efficiency for the effects of molecular size.
No comments:
Post a Comment